Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Gillani, Tina B.
Nair, Pramod C.
Text and Data Mining valid from 2019-10-21
21 July 2019
16 August 2019
21 October 2019
Compliance with Ethical Standards
The authors declare that they have no conflict of interest.